Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vaishali Pharma's share price for the quarter that ended in Mar. 2025 was ₹12.58. Vaishali Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 130.5 Mil. Therefore, Vaishali Pharma's market cap for the quarter that ended in Mar. 2025 was ₹1,641.2 Mil.
Vaishali Pharma's quarterly market cap
declined
from Sep. 2024 (₹2,513.7 Mil) to Dec. 2024 (₹2,281.8 Mil) and
declined
from Dec. 2024 (₹2,281.8 Mil) to Mar. 2025 (₹1,641.2 Mil).
Vaishali Pharma's annual market cap
declined
from Mar. 2023 (₹1,538.7 Mil) to Mar. 2024 (₹1,501.2 Mil) but then
increased
from Mar. 2024 (₹1,501.2 Mil) to Mar. 2025 (₹1,641.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vaishali Pharma's Enterprise Value for Today is ₹1,148.5 Mil.
Vaishali Pharma (NSE:VAISHALI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Vaishali Pharma Market Cap Related Terms
Vaishali Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Vaishali Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaishali Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Vaishali Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Vaishali Pharma's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaishali Pharma (NSE:VAISHALI) has a Market Cap of ₹1,042.4 Mil as of Aug. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vaishali Pharma and its competitors.
Is Vaishali Pharma's Market Cap too high?
Vaishali Pharma's current Market Cap is ₹1,042.4 Mil. Overall, Vaishali Pharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vaishali Pharma's Market Cap compare to ZTS?
Vaishali Pharma's Market Cap of ₹1,042.4 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 235.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 235.54, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Vaishali Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 235.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaishali Pharma's current Market Cap is ₹1,042.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaishali Pharma stock overvalued right now?
Vaishali Pharma (NSE:VAISHALI) has a current Market Cap of ₹1,042.4 Mil. The current Market Cap is ₹1,042.4 Mil. Vaishali Pharma's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Vaishali Pharma (NSE:VAISHALI), the current Market Cap is ₹1,042.4 Mil as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaishali Pharma Ltd is a pharmaceutical company. The Company is engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients.
52GF Score
Get the complete analysis for NSE:VAISHALI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VAISHALI has been successfully added to your 
